Signaling Between Tumor Cells and the Host Bone Marrow Microenvironment
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Signaling Between Tumor Cells and the Host Bone Marrow Microenvironment
Authors
Keywords
Myeloma, Breast cancer, Prostate cancer, Osteoblast, Osteoclast, Bone marrow
Journal
CALCIFIED TISSUE INTERNATIONAL
Volume 94, Issue 1, Pages 125-139
Publisher
Springer Nature
Online
2013-09-17
DOI
10.1007/s00223-013-9794-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
- (2013) Peter M. Voorhees et al. BRITISH JOURNAL OF HAEMATOLOGY
- Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies
- (2013) A. A. Zirakzadeh et al. JOURNAL OF IMMUNOLOGY
- Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy
- (2012) E. Terpos et al. ANNALS OF ONCOLOGY
- Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host
- (2012) Z Zhang et al. CANCER GENE THERAPY
- Bone Marrow Stromal Cells Create a Permissive Microenvironment for Myeloma Development: A New Stromal Role for Wnt Inhibitor Dkk1
- (2012) J. A. Fowler et al. CANCER RESEARCH
- Sclerostin: a possible target for the management of cancer-induced bone disease
- (2012) Maria Gkotzamanidou et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Depletion of Plasmacytoid Dendritic Cells Inhibits Tumor Growth and Prevents Bone Metastasis of Breast Cancer Cells
- (2012) Anandi Sawant et al. JOURNAL OF IMMUNOLOGY
- Disseminated Prostate Cancer Cells Can Instruct Hematopoietic Stem and Progenitor Cells to Regulate Bone Phenotype
- (2012) J. Joseph et al. MOLECULAR CANCER RESEARCH
- Endothelin antagonists in hypertension and kidney disease
- (2012) Kevin E. C. Meyers et al. PEDIATRIC NEPHROLOGY
- Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells
- (2012) Junling Zhuang et al. PLoS One
- Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer
- (2012) Ende Zhao et al. OncoImmunology
- Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction
- (2012) Sabrina Danilin et al. OncoImmunology
- Cooperative effects in differentiation and proliferation between PDGF-BB and matrix derived synthetic peptides in human osteoblasts
- (2011) Thomas Vordemvenne et al. BMC MUSCULOSKELETAL DISORDERS
- VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors
- (2011) Xin Lu et al. CANCER CELL
- Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells
- (2011) Nilay Sethi et al. CANCER CELL
- BMP4 Promotes Prostate Tumor Growth in Bone through Osteogenesis
- (2011) Y.-C. Lee et al. CANCER RESEARCH
- Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post-bortezomib monotherapy
- (2011) Evangelos Terpos et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor
- (2011) Gregory A Clines et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
- (2011) Yusuke Shiozawa et al. JOURNAL OF CLINICAL INVESTIGATION
- SDF-1 Induces PDGF-B Expression and the Differentiation of Bone Marrow Cells into Pericytes
- (2011) R. Hamdan et al. MOLECULAR CANCER RESEARCH
- PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells
- (2011) Yuan Xue et al. NATURE MEDICINE
- The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis
- (2011) Chiara Secondini et al. PLoS One
- Myeloma cells suppress osteoblasts through sclerostin secretion
- (2011) S Colucci et al. Blood Cancer Journal
- A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma
- (2010) K. Noonan et al. BLOOD
- Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis
- (2010) Conor C. Lynch BONE
- Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
- (2010) David G. DeNardo et al. CANCER AND METASTASIS REVIEWS
- Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis
- (2010) Pamela M. Holland et al. CANCER BIOLOGY & THERAPY
- Matrix Metalloproteinase (MMP)-13 Regulates Mammary Tumor–Induced Osteolysis by Activating MMP9 and Transforming Growth Factor-β Signaling at the Tumor-Bone Interface
- (2010) Kalyan C. Nannuru et al. CANCER RESEARCH
- TGF- Promotion of Gli2-Induced Expression of Parathyroid Hormone-Related Protein, an Important Osteolytic Factor in Bone Metastasis, Is Independent of Canonical Hedgehog Signaling
- (2010) R. W. Johnson et al. CANCER RESEARCH
- The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
- (2010) Je-In Youn et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo
- (2010) Andrew D Chantry et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
- (2010) Stephanie Markovina et al. Molecular Cancer
- Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease
- (2010) S. Vallet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases
- (2010) Nanda K. Thudi et al. PROSTATE
- The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth
- (2009) A. Pennisi et al. BLOOD
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
- (2009) M. Fulciniti et al. BLOOD
- Osteoclast-Derived Matrix Metalloproteinase-7, but Not Matrix Metalloproteinase-9, Contributes to Tumor-Induced Osteolysis
- (2009) S. Thiolloy et al. CANCER RESEARCH
- Bidirectional Signaling through EphrinA2-EphA2 Enhances Osteoclastogenesis and Suppresses Osteoblastogenesis
- (2009) Naoko Irie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin
- (2009) Kristy M. Nicks et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis
- (2009) A Seckinger et al. ONCOGENE
- Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms
- (2008) J. Dai et al. CANCER RESEARCH
- Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial
- (2008) Nicholas D. James et al. EUROPEAN UROLOGY
- Breast cancer‐derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: Implication for breast cancer osteolytic bone metastases
- (2008) Guojun Bu et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
- (2008) Deborah J Heath et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer
- (2008) Yusuke Shiozawa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis
- (2008) R. E. Miller et al. MOLECULAR CANCER THERAPEUTICS
- Osteoclasts Are Active in Bone Forming Metastases of Prostate Cancer Patients
- (2008) Ilaria Roato et al. PLoS One
- Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma
- (2007) Ya-Wei Qiang et al. BONE
- Metastatic breast cancer induces an osteoblast inflammatory response
- (2007) Michelle Kinder et al. EXPERIMENTAL CELL RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now